Epirubicin - NDC Database
22 records found
Page:
0143-9202 Aug 07, 2007
Epirubicin Hydrochloride 2 mg/ml Intravenous Injection by West-ward Pharmaceuticals Corp
Epirubicin Hydrochloride 2 mg/ml Intravenous Injection by West-ward Pharmaceuticals Corp
0143-9203 Aug 07, 2007
Epirubicin Hydrochloride 2 mg/ml Intravenous Injection by West-ward Pharmaceuticals Corp
Epirubicin Hydrochloride 2 mg/ml Intravenous Injection by West-ward Pharmaceuticals Corp
0703-3067 Aug 09, 2007
Epirubicin Hydrochloride 50 mg/25ml Intravenous Injection, Solution by Teva Parenteral Medicines, Inc.
Epirubicin Hydrochloride 50 mg/25ml Intravenous Injection, Solution by Teva Parenteral Medicines, Inc.
0703-3069 Aug 09, 2007
Epirubicin Hydrochloride 200 mg/100ml Intravenous Injection, Solution by Teva Parenteral Medicines, Inc.
Epirubicin Hydrochloride 200 mg/100ml Intravenous Injection, Solution by Teva Parenteral Medicines, Inc.
25021-203 Aug 31, 2014
Epirubicin Hydrochloride 2 mg/ml Intravenous Injection by Sagent Pharmaceutical
Epirubicin Hydrochloride 2 mg/ml Intravenous Injection by Sagent Pharmaceutical
45963-608 Jan 05, 2015
Epirubicin Hydrochloride 2 mg/ml Intravenous Injection by Actavis Pharma, Inc.
Epirubicin Hydrochloride 2 mg/ml Intravenous Injection by Actavis Pharma, Inc.
53150-247 Jul 31, 2013
Epirubicin Hydrochloride 200 mg/100ml Intravenous Injection by Amneal-agila, LLC
Epirubicin Hydrochloride 200 mg/100ml Intravenous Injection by Amneal-agila, LLC
53150-250 Jul 31, 2013
Epirubicin Hydrochloride 50 mg/25ml Intravenous Injection by Amneal-agila, LLC
Epirubicin Hydrochloride 50 mg/25ml Intravenous Injection by Amneal-agila, LLC
55390-207 Aug 07, 2007
Epirubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Bedford Laboratories
Epirubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Bedford Laboratories
55390-208 Aug 07, 2007
Epirubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Bedford Laboratories
Epirubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Bedford Laboratories
59762-5091 Sep 15, 1999
Epirubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Greenstone, LLC
Epirubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Greenstone, LLC
59762-5093 Sep 15, 1999
Epirubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Greenstone, LLC
Epirubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Greenstone, LLC
59923-701 May 19, 2014
Epirubicin Hydrochloride 2 mg/ml Intravenous Injection by Areva Pharmaceuticals, Inc.
Epirubicin Hydrochloride 2 mg/ml Intravenous Injection by Areva Pharmaceuticals, Inc.
61703-347 Sep 15, 2006
Epirubicin Hydrochloride 50 mg/25ml Intravenous Injection, Powder, Lyophilized, for Solution by Hospira Worldwide, Inc.
Epirubicin Hydrochloride 50 mg/25ml Intravenous Injection, Powder, Lyophilized, for Solution by Hospira Worldwide, Inc.
61703-348 Sep 15, 2006
Epirubicin Hydrochloride 200 mg/100ml Intravenous Injection, Powder, Lyophilized, for Solution by Hospira Worldwide, Inc.
Epirubicin Hydrochloride 200 mg/100ml Intravenous Injection, Powder, Lyophilized, for Solution by Hospira Worldwide, Inc.
61703-359 Apr 19, 2007
Epirubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Hospira Worldwide, Inc.
Epirubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Hospira Worldwide, Inc.
63323-151 Jul 31, 2017
Epirubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Fresenius Kabi USA, LLC
Epirubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Fresenius Kabi USA, LLC
66758-042 Dec 22, 2009
Epirubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Sandoz Inc
Epirubicin Hydrochloride 2 mg/ml Intravenous Injection, Solution by Sandoz Inc
Page:
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.